Home
Conditions
Attention Deficit Disorder with Hyperactivity

Clinical trial condition

Attention Deficit Disorder with Hyperactivity

Explore clinical trials studying Attention Deficit Disorder with Hyperactivity. Study availability and eligibility vary by location and protocol.

1,408 public trials 160 recruiting studies

Refine in advanced search Browse all conditions

Attention Deficit Disorder with Hyperactivity trial results

Completed

A Study of PDC-1421 Treatment in Adult Patients With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT02699086

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit Hyperactivity Disorder (ADHD), +2 more
Locations: UCSF Medical Center San Francisco, California, United States

View Trial Details

Completed

Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia

NCT05138224

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +16 more
Locations: Not specified

View Trial Details

Completed

Pharmacokinetic Study of Methylphenidate HCl Extended-Release Capsules in Children 4 to Under 6 Years of Age With ADHD

NCT02470234

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder, +2 more
Locations: Qps-Mra, Llc South Miami, Florida, United States

Duke Psychiatry and Behavioral Sciences, Duke University School of Medicine Durham, North Carolina, United States

View Trial Details

Completed

Shire SCT: Lisdexamfetamine Treatment for ADHD and SCT

NCT02635035

Conditions: Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
Locations: Mount Sinai School of Medicine New York, United States

New York University School of Medicine New York, United States

View Trial Details

Completed

Safety and Efficacy Study of Centanafadine Sustained-Release (CTN SR) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

NCT02547428

Conditions: Attention Deficit Disorder With Hyperactivity, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Newport Beach, California, United States

Bradenton, Florida, United States

Maitland, Florida, United States

Las Vegas, Nevada, United States

View Trial Details

Completed

Task-Based Grounding Program

NCT04648553

Conditions: Aberrant Motor Behavior in Dementia, Aggression, Aggressive, +10 more
Locations: Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

NCT03324581

Conditions: Adult Attention Deficit Hyperactivity Disorder, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Southern California Research, LLC Beverly Hills, California, United States

Collaborative Neuroscience Network, LLC Garden Grove, California, United States

Artemis Institute for Clinical Research San Diego, California, United States

Artemis Institute for Clinical Research San Marcos, California, United States

View all 26 locations

View Trial Details

Completed

Open Trial of a Program to Support Parents of Children With Attention-deficit/Hyperactivity Disorder (ADHD)

NCT04636216

Conditions: ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations: Center for Children and Families Amherst, New York, United States

View Trial Details

Completed

Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD

NCT02633527

Conditions: Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, Attention-Deficit/Hyperactivity Disorder (ADHD), +2 more
Locations: Florida Clinical Research Center, LLC Maitland, Florida, United States

View Trial Details

Completed

A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder

NCT03605836

Conditions: Attention Deficit Disorder, Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, +3 more
Locations: For additional information regarding sites, contact 844-687-8522 Orlando, Florida, United States

View Trial Details

Attention Deficit Disorder with Hyperactivity

Attention Deficit Disorder with Hyperactivity trial results

Related conditions